Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Overview of biological effects of addition of DNA molecules to cells.

Temin HM.

Dev Biol Stand. 1998;93:37-44. Review.

PMID:
9737375
2.

In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex.

Boris-Lawrie K, Altanerova V, Altaner C, Kucerova L, Temin HM.

J Virol. 1997 Feb;71(2):1514-20.

3.
5.

Genetics of retroviruses.

Temin HM.

Ann N Y Acad Sci. 1995 Jun 30;758:161-5. Review. No abstract available.

PMID:
7542856
6.
7.
8.
10.
11.

The retroviral vector. Replication cycle and safety considerations for retrovirus-mediated gene therapy.

Boris-Lawrie K, Temin HM.

Ann N Y Acad Sci. 1994 May 31;716:59-70; discussion 71. Review. No abstract available.

PMID:
8024209
12.
14.
15.

One retroviral RNA is sufficient for synthesis of viral DNA.

Jones JS, Allan RW, Temin HM.

J Virol. 1994 Jan;68(1):207-16.

16.
18.
19.

3' junctions of oncogene-virus sequences and the mechanisms for formation of highly oncogenic retroviruses.

Zhang J, Temin HM.

J Virol. 1993 Apr;67(4):1747-51. Review. No abstract available.

20.

AIDS. Where has HIV been hiding?

Temin HM, Bolognesi DP.

Nature. 1993 Mar 25;362(6418):292-3. No abstract available.

PMID:
8455713
21.

Recent advances in retrovirus vector technology.

Boris-Lawrie KA, Temin HM.

Curr Opin Genet Dev. 1993 Feb;3(1):102-9. Review.

PMID:
8453267
22.
23.

Effect of gamma radiation on retroviral recombination.

Hu WS, Temin HM.

J Virol. 1992 Jul;66(7):4457-63.

24.
26.

Why are there so many leukemia viruses?

Temin HM.

Leukemia. 1992;6 Suppl 3:4S-5S. No abstract available.

PMID:
1602825
27.

RNA-dependent DNA polymerase in virions of Rous sarcoma virus. 1970.

Temin HM, Mizutani S.

Biotechnology. 1992;24:51-6. No abstract available.

PMID:
1384844
28.
30.

Sex and recombination in retroviruses.

Temin HM.

Trends Genet. 1991 Mar;7(3):71-4. Review. No abstract available.

PMID:
2031285
31.

Determination of retroviral mutation rates using spleen necrosis virus-based vectors and helper cells.

Dougherty JP, Temin HM.

Biotechnology. 1991;16:21-33. No abstract available.

PMID:
2007191
32.

Molecular mechanisms of transformation by the v-rel oncogene.

Hannink M, Temin HM.

Crit Rev Oncog. 1991;2(4):293-309. Review.

PMID:
1958712
33.

Structure and autoregulation of the c-rel promoter.

Hannink M, Temin HM.

Oncogene. 1990 Dec;5(12):1843-50.

PMID:
2284104
35.
36.

Retroviral recombination and reverse transcription.

Hu WS, Temin HM.

Science. 1990 Nov 30;250(4985):1227-33.

PMID:
1700865
39.
40.

Overview of biological effects of addition of DNA molecules to cells.

Temin HM.

J Med Virol. 1990 May;31(1):13-7. Review.

PMID:
2142957
43.

Retroviruses and cancer.

Temin HM.

Mol Carcinog. 1990;3(4):183-4. No abstract available.

PMID:
2206280
45.

Safety considerations in somatic gene therapy of human disease with retrovirus vectors.

Temin HM.

Hum Gene Ther. 1990 Summer;1(2):111-23. Review.

PMID:
2078575
46.

Retrovirus vectors: promise and reality.

Temin HM.

Science. 1989 Nov 24;246(4933):983. Review. No abstract available.

PMID:
2686028
47.

Transactivation of gene expression by nuclear and cytoplasmic rel proteins.

Hannink M, Temin HM.

Mol Cell Biol. 1989 Oct;9(10):4323-36.

48.

Bovine leukaemia virus packaging cell line for retrovirus-mediated gene transfer.

Ban J, First NL, Temin HM.

J Gen Virol. 1989 Aug;70 ( Pt 8):1987-93.

PMID:
2549178
49.

New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors.

Dougherty JP, Wisniewski R, Yang SL, Rhode BW, Temin HM.

J Virol. 1989 Jul;63(7):3209-12.

50.

Reverse transcriptases. Retrons in bacteria.

Temin HM.

Nature. 1989 May 25;339(6222):254-5. No abstract available.

PMID:
2471077

Supplemental Content

Loading ...
Support Center